STI 0.00% 0.2¢ stirling products limited

Immediate revenues to be generated through Stirling Products...

  1. 103 Posts.
    Immediate revenues to be generated through Stirling Products North
    America Inc.
    • Focused scale-up as Stirling expands new business phase.
    Stirling Products Limited (ASX:STI) advises shareholders that it will immediately
    commence generating revenues through the newly formed North America subsidiary
    Stirling Product North America Inc.
    Following the recent approval by Stirling shareholders on August 22 (ASX: August 22,
    2007), final transactions for the completion of the acquisition were held at the Canadian
    Consulate in Sydney on Friday August 24. The signing of the Share Sale and Purchase
    agreements was attended by the Canadian Consul General, Deputy Consul General and
    other members of the Canadian Trade Commission.
    “This is a great outcome. It provides revenue, cash flow and a tangible, approved
    product to grow market share and brand awareness. The other great benefit is that it
    provides a sales and distribution pathway to market for our new and innovative Rsalbutamol
    products,” said Stirling Products Limited CEO Dr Calvin London.
    Stirling Products North America Inc. (which will continue to trade as Progressive
    BioActives Incorporated, PBI) has acquired technology to extract and produce natural
    bioactive ingredients for immune health & productivity solution for the agriculture,
    aquaculture and pet feed industries. Stirling will tap into the US$15 billion animal feed
    additives market with PBI’s existing beta glucan product, ProVale™ as well as Stirling’s
    own growth promoters which are under development.
    At the Board meeting of Stirling Products late last week, approval was given for the first
    stage of expansion to the Prince Edward Island facility, which will double the company’s
    output and a cost of less than CAD$100K.
    “This deal is all about synergy allowing us to combine our respective technologies for
    mutual benefit and global growth in all markets especially the Americas, with a range of
    complementary animal health products,” said Dr London. “Stirling will ensure that we
    are in a position to supply product to customers before they sign distribution agreements
    with us. As we have just signed some new agreements (ASX July 30, 2007), we now
    need to go to the next stage of production,” he added.
    ENDS.
    For personal
 
watchlist Created with Sketch. Add STI (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.